Predictive Oncology Inc. (POAI)
NASDAQ: POAI
· Real-Time Price · USD
13.60
0.02 (0.15%)
At close: Oct 15, 2025, 3:59 PM
13.05
-4.03%
After-hours: Oct 15, 2025, 07:59 PM EDT
Predictive Oncology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 1.62M | 1.78M | 1.51M | 1.42M |
Cost of Revenue | 826.14K | 609.21K | 505.11K | 487.02K |
Gross Profit | 797.68K | 1.02M | 1M | 933.66K |
Operating Income | -10.94M | -12.12M | -26.03M | -20.43M |
Interest Income | n/a | n/a | n/a | n/a |
Pretax Income | -10.86M | -13.98M | -25.74M | -20.32M |
Net Income | -12.2M | -13.98M | -25.74M | -19.66M |
Selling & General & Admin | 8.89M | 13.14M | 12.47M | 11.71M |
Research & Development | 25.99K | 122.31K | 320.32K | 315.85K |
Other Expenses | 2.83M | -122.31K | 14.24M | 9.34M |
Operating Expenses | 11.74M | 13.14M | 27.03M | 21.36M |
Interest Expense | n/a | n/a | 10.65M | n/a |
Selling & Marketing Expenses | 1.47M | 1.49M | 1.36M | 774.53K |
Cost & Expenses | 12.56M | 13.75M | 27.54M | 21.85M |
Income Tax Expense | n/a | n/a | n/a | -661.66K |
Shares Outstanding (Basic) | 5.45M | 4.01M | 3.69M | 2.73M |
Shares Outstanding (Diluted) | 5.45M | 4.01M | 3.69M | 2.74M |
EPS (Basic) | -2.24 | -3.48 | -6.98 | -7.16 |
EPS (Diluted) | -2.24 | -3.48 | -6.98 | -7.2 |
EBITDA | -10.24M | -13.18M | -13.95M | -12.13M |
EBIT | -10.94M | -13.92M | -15.27M | -13.47M |
Depreciation & Amortization | 695.66K | 739.32K | 1.31M | 1.34M |
Source: Financial Modeling Prep. Financial Sources.